5-ethynyl-1-ribofuranosylimidazole-4-carboxamide has been researched along with hypoxanthine in 1 studies
| Studies (5-ethynyl-1-ribofuranosylimidazole-4-carboxamide) | Trials (5-ethynyl-1-ribofuranosylimidazole-4-carboxamide) | Recent Studies (post-2010) (5-ethynyl-1-ribofuranosylimidazole-4-carboxamide) | Studies (hypoxanthine) | Trials (hypoxanthine) | Recent Studies (post-2010) (hypoxanthine) |
|---|---|---|---|---|---|
| 21 | 0 | 2 | 2,529 | 65 | 361 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balzarini, J; De Clercq, E | 1 |
1 other study(ies) available for 5-ethynyl-1-ribofuranosylimidazole-4-carboxamide and hypoxanthine
| Article | Year |
|---|---|
Assay method for monitoring the inhibitory effects of antimetabolites on the activity of inosinate dehydrogenase in intact human CEM lymphocytes.
Topics: Adenosine Triphosphate; Antimetabolites; Cell Line; Guanosine Triphosphate; Humans; Hypoxanthine; Hypoxanthines; IMP Dehydrogenase; Inosine; Inosine Monophosphate; Kinetics; Lymphocytes; Ribonucleosides | 1992 |